Zika Virus: A Comprehensive Review

Snehal Dilip Kothavale; Rinaj Rasul Attar; Dr. S. K. Mohite; Sagar B. Patil

doi:10.52711/2321-5836.2023.00006

Research Journal of Pharmacology and Pharmacodynamics

ISSN

2321-5836 (Online)
0975-4407 (Print)

Submit Article

Zika Virus: A Comprehensive Review

Author(s): Snehal Dilip Kothavale, Rinaj Rasul Attar, Dr. S. K. Mohite, Sagar B. Patil

Email(s): snehalkothavale28@gmail.com , Patil.sagar0505@gmail.com

DOI: 10.52711/2321-5836.2023.00006

Address: Snehal Dilip Kothavale, Rinaj Rasul Attar, Dr. S. K. Mohite, Sagar B. Patil
Rajarambapu College of Pharmacy, Kasegoan, Maharashtra, 415404.
*Corresponding Author

Published In: Volume - 15, Issue - 1, Year - 2023

View HTML

View PDF

ABSTRACT:
The Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) belonging to the Flavivirus genus and the Flaviviridae family. Aedes mosquito species such as Aedes aegypti, Aedes albopict us, and Aedes africanus transmit the disease to humans.

Keywords:

Cite this article:
Snehal Dilip Kothavale, Rinaj Rasul Attar, Dr. S. K. Mohite, Sagar B. Patil. Zika Virus: A Comprehensive Review. Research Journal of Pharmacology and Pharmacodynamics 2023;15(1):24-0. doi: 10.52711/2321-5836.2023.00006

Cite(Electronic):
Snehal Dilip Kothavale, Rinaj Rasul Attar, Dr. S. K. Mohite, Sagar B. Patil. Zika Virus: A Comprehensive Review. Research Journal of Pharmacology and Pharmacodynamics 2023;15(1):24-0. doi: 10.52711/2321-5836.2023.00006 Available on: https://rjppd.org/AbstractView.aspx?PID=2023-15-1-6

REFERENCES:
1.   Musso. D, Gubler D.J; Clinical Microbiology review; 2016; volume 3; 487-524
2.   Musso D, Ko AI, Baud D. Zika Virus Infection - After the Pandemic. N Engl J Med. 2019:1444-1457.
3.   Noorbakhsh F, Abdolmohammadi K, Fatahi Y, Dalili H, Rasoolinejad M, Rezaei F, Salehi-Vaziri M, Shafiei-Jandaghi NZ, Gooshki ES, Zika Virus Infection, Basic and Clinical Aspects: A Review Article. Iran J Public Health. 2019; 20-31
4.   Faria NR, Azevedo RDSDS, Kraemer MUG. Zika virus in the Americas: Early epidemiological and genetic findings:345-349.
5.   Kindhauser, M. K., Allen, T., Frank, V., Santhana, R. S., and Dye, C.; Zika: the origin and spread of a mosquito-borne virus. Bulletin of the World Health Organization, 675–686
6.   Gorshkov K, Shiryaev SA, Fertel S, Lin YW, Huang CT, Pinto A, Farhy C, Strongin AY, Zheng W, Terskikh AV. Zika Virus: Origins, Pathological Action, and Treatment Strategies. Front Microbiol. 2019; 3252.
7.   Pierson TC’Diamond MS. ‘The emergence of zika virus and its new clinical syndromes’.573-581
8.   Gubler, D. J., Vasilakis, N., and Musso, D.; History and Emergence of Zika Virus. The Journal of infectious diseases, 2017; 860–867.
9.   Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. An update on Zika virus infection. Lancet. 2017:2099-2109.
10.   Weaver SC, Costa F, Garcia-Blanco MA, et al. Zika virus: History, emergence, biology, and prospects for control, 2016; 69-80.
11.   Yun, S. I., and Lee, Y. M.; Zikavirus:An emerging flavivirus. Journal of microbiology; 2017; 204–219
12.   Al-Abdely H. M.; Zika:An emerging teratogenic virus. Saudi medical journal; 2017; 831–833
13.   Yasri, S., and Wiwanitkit, V.; EmergingZika virus. Saudi medical journal, 1417
14.   FigueiredoL.; Has the threat of Zika virus outbreaks come to an end?. Revista da SociedadeBrasileira de Medicina Tropical, 2018, 259–260
15.   Pettersson, J. H., Bohlin, J., Dupont-Rouzeyrol, M., Brynildsrud, O. B., Alfsnes, K., Cao-Lormeau, V. M., Gaunt, M. W., Falconar, A. K., de Lamballerie, X., Eldholm, V., Musso, D., and Gould, E. A.Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia. Emerging microbes and infection, 79
16.   Duong, V., Dussart, P., and Buchy, p; Zika virus in Asia. International journal of infectious diseases :official publication of the International Society for Infectious Diseases, 121–128
17.   Pielnaa P, Al-Saadawe M, Saro A, et al. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development, 2020; 34-42
18.   Christian, K. M., Song, H., and Ming, G. L.; Pathophysiology and Mechanisms of Zika Virus Infection in the Nervous System. Annual review of neuroscience, 2017, 249–269
19.   Kazmi, S. S., Ali, W., Bibi, N., and Nouroz, F; A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. Journal of biological research, 2020, 27
20.   Bearcroft WG. Zika virus infection experimentally induced in a human volunteer, 442-448.
21.   Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007; 1232-1239
22.   Driggers RW, Ho C-Y, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities.
23.   Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 984-99
24.   Roehrig JT, Hombach J, Barrett AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol 2008; 123-132
25.   Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. Emerg Infect 2010; 1023-1024
26.   Mohammed H, Tomashek KM, Stramer SL, Hunsperger E. Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006. Transfusion; 1652-1656
27.   Rozé B, Najioullah F, Fergé JL, et al. Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, 2016. Euro Surveill 2016; 21
28.   Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis 2015; 84-86
29.   Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of Zika virus in saliva. J ClinVirol. 2015; 53-5
30.   Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD); 2019
31.   Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure — United States, 2016; 122-127
32.   Brunkard JM, Robles López JL, Ramirez J, et al. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 2007; 1477-1483
33.   Reiter P, Lathrop S, Bunning M, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 2003; 9:86-89
34.   Heintze C, Velasco Garrido M, Kroeger A. What do community-based dengue control programmes achieve? A systematic review of published evaluations. Trans R Soc Trop Med Hyg 2007; 317-325
35.   Vazquez-Prokopec GM, Kitron U, Montgomery B, Horne P, Ritchie SA. Quantifying the spatial dimension of dengue virus epidemic spread within a tropical urban environment. PLoSNegl Trop Dis 2010; 920
36.   Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med 2016; 374
37.   Simeone RM, Shapiro-Mendoza CK, Meaney-Delman D, et al.; Zika and Pregnancy Working Group. Possible Zika virus infection among pregnant women—United States and territories, MMWRMorb Mortal Wkly Rep 2016; 65
38.   Russell K, Oliver SE, Lewis L, et al.Interim guidance for the evaluation and management of infants with possible congenital Zika virus infection; 2016; 65
39.   Gabriela paz-bailey, Rosenberg, Katedayol, Jorgmuzoz Jordan: Persistaence of zika virus in Body fluids-final report. The new Eng J; 2018; 2
40.   Zou J, Shi PY. Strategies for Zika drug discovery. CurrOpinVirol. 2019; 19-26
41.   Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. 2017; 148-157
42.   Stephen J. Thomus, M.D. Maina L AZou, Barret Nicholus AC Jackson: Fast-Track ZIKA Vaccine Development-It Is Possible?; The New Eng J; 2016; 1-5